151 related articles for article (PubMed ID: 9137907)
41. The Caenorhabditis elegans gene T23G5.5 encodes an antidepressant- and cocaine-sensitive dopamine transporter.
Jayanthi LD; Apparsundaram S; Malone MD; Ward E; Miller DM; Eppler M; Blakely RD
Mol Pharmacol; 1998 Oct; 54(4):601-9. PubMed ID: 9765501
[TBL] [Abstract][Full Text] [Related]
42. Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain.
Madras BK; Gracz LM; Fahey MA; Elmaleh D; Meltzer PC; Liang AY; Stopa EG; Babich J; Fischman AJ
Synapse; 1998 Jun; 29(2):116-27. PubMed ID: 9593102
[TBL] [Abstract][Full Text] [Related]
43. 2-Carbomethoxy-3-(diarylmethoxy)-1 alpha H, 5 alpha H-tropane analogs: synthesis and inhibition of binding at the dopamine transporter and comparison with piperazines of the GBR series.
Meltzer PC; Liang AY; Madras BK
J Med Chem; 1996 Jan; 39(2):371-9. PubMed ID: 8558504
[TBL] [Abstract][Full Text] [Related]
44. Prenatal cocaine exposure affects postnatal dopaminergic systems in various regions of the rat brain.
Choi SJ; Mazzio E; Kolta MG; Soliman KF
Ann N Y Acad Sci; 1998 May; 844():293-302. PubMed ID: 9668686
[TBL] [Abstract][Full Text] [Related]
45. Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation.
Bellucci A; Collo G; Sarnico I; Battistin L; Missale C; Spano P
J Neurochem; 2008 Jul; 106(2):560-77. PubMed ID: 18410503
[TBL] [Abstract][Full Text] [Related]
46. Dopamine transporter mediated release of dopamine: role of chloride.
Sitges M; Reyes A; Chiu LM
J Neurosci Res; 1994 Sep; 39(1):11-22. PubMed ID: 7807588
[TBL] [Abstract][Full Text] [Related]
47. Effect of dopaminergic drugs on the in vivo binding of [3H]WIN 35,428 to central dopamine transporters.
Scheffel U; Steinert C; Kim SE; Ehlers MD; Boja JW; Kuhar MJ
Synapse; 1996 Jun; 23(2):61-9. PubMed ID: 8723710
[TBL] [Abstract][Full Text] [Related]
48. Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter.
Bezard E; Gross CE; Fournier MC; Dovero S; Bloch B; Jaber M
Exp Neurol; 1999 Feb; 155(2):268-73. PubMed ID: 10072302
[TBL] [Abstract][Full Text] [Related]
49. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
Rothman RB; Cadet JL; Akunne HC; Silverthorn ML; Baumann MH; Carroll FI; Rice KC; de Costa BR; Partilla JS; Wang JB
J Pharmacol Exp Ther; 1994 Jul; 270(1):296-309. PubMed ID: 8035327
[TBL] [Abstract][Full Text] [Related]
50. Neuroleptic drugs alter the dopamine transporter-mediated uptake and release of dopamine: a possible mechanism for drug-induced tardive dyskinesia.
Lee SH; Oh DY; Jung SC; Kim YM; Cho HK; Koh JK; Lee YS
Pharmacol Res; 1997 May; 35(5):447-50. PubMed ID: 9308073
[TBL] [Abstract][Full Text] [Related]
51. Individual and combined effects of ethanol and cocaine on the human dopamine transporter in neuronal cell lines.
Ho M; Segre M
Neurosci Lett; 2001 Feb; 299(3):229-33. PubMed ID: 11165777
[TBL] [Abstract][Full Text] [Related]
52. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate.
Volkow ND; Wang GJ; Fowler JS; Gatley SJ; Logan J; Ding YS; Hitzemann R; Pappas N
Am J Psychiatry; 1998 Oct; 155(10):1325-31. PubMed ID: 9766762
[TBL] [Abstract][Full Text] [Related]
53. Characterization of a tropane radioligand, [(3)H]2beta-propanoyl-3beta-(4-tolyl) tropane ([(3)H]PTT), for dopamine transport sites in rat brain.
Letchworth SR; Smith HR; Porrino LJ; Bennett BA; Davies HM; Sexton T; Childers SR
J Pharmacol Exp Ther; 2000 May; 293(2):686-96. PubMed ID: 10773045
[TBL] [Abstract][Full Text] [Related]
54. Molecular serotonergic mechanisms appear to mediate genetic sensitivity to cocaine-induced convulsions.
O'Dell LE; Li R; George FR; Ritz MC
Brain Res; 2000 Apr; 863(1-2):213-24. PubMed ID: 10773209
[TBL] [Abstract][Full Text] [Related]
55. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding.
Pristupa ZB; Wilson JM; Hoffman BJ; Kish SJ; Niznik HB
Mol Pharmacol; 1994 Jan; 45(1):125-35. PubMed ID: 8302271
[TBL] [Abstract][Full Text] [Related]
56. 3'-Chloro-3 alpha-(diphenylmethoxy)tropane but not 4'-chloro-3 alpha-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile.
Kline RH; Izenwasser S; Katz JL; Joseph DB; Bowen WD; Newman AH
J Med Chem; 1997 Mar; 40(6):851-7. PubMed ID: 9083473
[TBL] [Abstract][Full Text] [Related]
57. Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkey.
Farfel GM; Kleven MS; Woolverton WL; Seiden LS; Perry BD
Brain Res; 1992 Apr; 578(1-2):235-43. PubMed ID: 1380862
[TBL] [Abstract][Full Text] [Related]
58. Hypothesis: the role of dopaminergic transporters in selective vulnerability of cells in Parkinson's disease.
Uhl GR
Ann Neurol; 1998 May; 43(5):555-60. PubMed ID: 9585349
[No Abstract] [Full Text] [Related]
59. High-affinity binding of [125I]RTI-55 to dopamine and serotonin transporters in rat brain.
Boja JW; Mitchell WM; Patel A; Kopajtic TA; Carroll FI; Lewin AH; Abraham P; Kuhar MJ
Synapse; 1992 Sep; 12(1):27-36. PubMed ID: 1411961
[TBL] [Abstract][Full Text] [Related]
60. Unraveling neuronal dopamine transporter mechanisms with rotating disk electrode voltammetry.
Schenk JO; Wright C; Bjorklund N
J Neurosci Methods; 2005 Apr; 143(1):41-7. PubMed ID: 15763135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
